Perioperative Care for Patients With Sickle Cell Who Are Undergoing Total Hip Replacement as Treatment for Osteonecrosis
| Autor: | Marjorie Hammer, Kathleen A. Geier, H M Reynolds, Sara Aksoy |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Pediatrics
medicine.medical_specialty Anemia Arthroplasty Replacement Hip medicine.medical_treatment Cell Anemia Sickle Cell Disease Patient Care Planning Perioperative Care Femoral head Clinical Protocols Femur Head Necrosis Risk Factors medicine Humans Blood Transfusion Orthopedics and Sports Medicine Advanced and Specialized Nursing business.industry medicine.disease Arthroplasty Sickle cell anemia Pathophysiology Surgery medicine.anatomical_structure Perioperative care Orthopedic Nursing business |
| Zdroj: | Orthopaedic Nursing. 22:384-397 |
| ISSN: | 0744-6020 |
| DOI: | 10.1097/00006416-200311000-00004 |
| Popis: | Sickle cell disease, which is characterized by chronic hemolytic anemia, is prevalent in the United States. In addition to the profound multisystem effects of vasoocclusion associated with sickle cell disease, osteonecrosis of the femoral head classically develops at an early age. Because of advanced medical technology and new treatment modalities, patients with sickle cell disease are living longer. More adults with this genetic disease are becoming candidates for total hip arthroplasty. This article describes the pathophysiology of sickle cell anemia, explains the process of osteonecrosis, and discusses total hip arthroplasty in this unique patient population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|